Search Within

Mark Andrew Dickson

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (25)
Groups
  1. Department of Medicine (58)
  2. GSK Faculty (58)
  3. Human Oncology and Pathogenesis Program (58)
  4. Sarcoma Service (58)
  5. Solid Tumor Oncology Division (58)
  6. Tow Center for Developmental Oncology (TCDO) (57)

More Groups

People
  1. Sandra D'Angelo (55)
  2. Ping Chi (54)
  3. Mary Keohan (53)
  4. Mrinal Gounder (53)
  5. William Tap (53)
  6. Ciara Kelly (42)

More People

Years
  1. 2024 (8)
  2. 2023 (6)
  3. 2022 (13)
  4. 2021 (2)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (5)
  4. Nature Communications (3)
  5. JAMA Oncology (2)
  6. The Oncologist (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (4)
  5. American Medical Association (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical impact of performing routine next generation sequencing (NGS) in gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Vonya, T.; Yoon, S. S.; Singer, S.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas: A phase Ib study of dasatinib plus ipilimumab
    Journal Article

    D'Angelo, S. P.; Shoushtari, A. N.; Keohan, M. L.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Loo, J. K.; Gaffney, L.; Schneider, L.; Patel, Z.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Efficacy of sorafenib in patients with desmoid-type fibromatosis
    Meeting Abstract

    Munhor, R. R.; Lefkowitz, R. A.; Kuk, D.; Dickson, M. A.; D'Angelo, S. P.; Keohan, M. L.; Chi, P.; Crago, A. M.; Maki, R. G.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic undifferentiated pleomorphic sarcoma (UPS)
    Meeting Abstract

    Adrianzen Herrera, D. A.; Kuk, D.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Agaram, N. P.; Antonescu, C. R.; Hameed, M.; Tap, W. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial
    Journal Article

    Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Overall survival and response to systemic therapy in metastatic extrauterine leiomyosarcoma
    Journal Article

    Shoushtari, A. N.; Landa, J.; Kuk, D.; Sanchez, A.; Lala, B.; Schmidt, N.; Okoli, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; more...
    Sarcoma (2016)

    Fulltext@MSK | Save